Citigroup’s aTyr Pharma ATYR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.59K Buy
5,891
+2,821
+92% +$2.38K ﹤0.01% 5281
2025
Q4
$2.4K Sell
3,070
-2,647
-46% -$2.17K ﹤0.01% 5426
2025
Q3
$4.12K Sell
5,717
-27,616
-83% -$125K ﹤0.01% 5286
2025
Q2
$169K Buy
33,333
+33,332
+3,333,200% +$131K ﹤0.01% 4147
2025
Q1
$3 Sell
1
-104,479
-100% -$381K ﹤0.01% 5515
2024
Q4
$378K Sell
104,480
-28,503
-21% -$86.3K ﹤0.01% 4017
2024
Q3
$234K Buy
+132,983
New +$242K ﹤0.01% 4237
2024
Q2
Sell
-78,620
Closed -$153K 5832
2024
Q1
$153K Hold
78,620
﹤0.01% 4128
2023
Q4
$111K Buy
+78,620
New +$101K ﹤0.01% 4161
2023
Q1
Sell
-428,460
Closed -$938K 5943
2022
Q4
$938K Buy
+428,460
New +$1.01M ﹤0.01% 2656
2022
Q2
Sell
-650
Closed -$3K 6761
2022
Q1
$3K Buy
+650
New +$3.68K ﹤0.01% 5999
2018
Q1
Sell
-36
Closed -$2K 7700
2017
Q4
$2K Sell
36
-485
-93% -$29.8K ﹤0.01% 7406
2017
Q3
$37K Sell
521
-36
-6% -$1.67K ﹤0.01% 6153
2017
Q2
$27K Hold
557
﹤0.01% 6145
2017
Q1
$27K Buy
557
+21
+4% +$960 ﹤0.01% 6093
2016
Q4
$16K Sell
536
-309
-37% -$12.7K ﹤0.01% 6612
2016
Q3
$37K Buy
845
+643
+318% +$27.8K ﹤0.01% 5861
2016
Q2
$8K Sell
202
-364
-64% -$16.9K ﹤0.01% 6647
2016
Q1
$31K Buy
566
+197
+53% +$15K ﹤0.01% 6346
2015
Q4
$51K Buy
369
+364
+7,280% +$51.8K ﹤0.01% 5931
2015
Q3
$1K Sell
5
-1
-17% -$228 ﹤0.01% 7233
2015
Q2
$1K Buy
+6
New +$1.86K ﹤0.01% 7351

Other funds holding ATYR